Regeneron Pharmaceuticals
The Director, Development Program Management provides operational leadership for drug development programs, overseeing activities from preclinical through commercialization. This role drives integrated program plans, goals, budgets and timelines, and represents the program with internal and external stakeholders. The director ensures program success and aligns cross-functional teams to strategic objectives.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior Director, Program Lead
Deciphera Pharmaceuticals
Director, Program Management
Rhythm Pharmaceuticals
Senior Director, Program Management
Rigel Pharmaceuticals
Director, Drug Product
Intuitive
Program Executive - Drug Development
Praxis Precision Medicines, Inc.
Sr. Program Manager - Drug Development (Immunology)
Neurocrine Biosciences